Empower Pharmacy
One of the largest US compounders by volume; dual 503A + 503B. Repeat FDA enforcement history and ongoing Lilly litigation.
High-volume dual 503A/503B pharmacy. Supplies major telehealth partners (Mochi, Lavender Sky). Catalog historically included BPC-157 and CJC-1295/Ipamorelin before Category 2 restrictions; today focused on compoundable peptides (Sermorelin, Tesamorelin, PT-141, Oxytocin, HCG, Gonadorelin, NAD+).
Credentials
- FDA 503B Registered
Flags · curated
- FDA Warning Letter · 2025-04-02Warning letter #700964: sterile drug deficiencies, stopper sterility
- FDA Warning Letter · 2021Prior warning letter
- FDA Warning Letter · 2017Prior warning letter
- Form 483 Observation · 2024Semaglutide fill-weight discrepancies
- Form 483 Observation · 2025-11November 2025 observations
- Ongoing Litigation · 2025-04Eli Lilly suit over compounded tirzepatide with niacinamide/B12 and ODT formulation
Auto-detected · last 12 months
- Class II: Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multip…OpenFDA · May 2, 2025 · Lack of Assurance of Sterility
- Class II: Pyridoxine HCL (B6) Injection Solution, 100mg/mL, 30 mL Sterile Multiple-Dose V…OpenFDA · Sep 5, 2024 · Lack of Assurance of Sterility
- Class II: Empower Pharmacy, Estradiol Cypionate Injection, 10mg/mL, 5mL Sterile Multiple …OpenFDA · Aug 2, 2024 · Lack of Assurance of Sterility
- Class II: ASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-D…OpenFDA · May 12, 2023 · Mislabeling: preservative free product labeled as preserved.